Gamfexine

Gamfexine (WIN-1,344) is a centrally acting stimulant drug, which was tested as an adjunct treatment for withdrawn patients with schizophrenia, but while effective for treating withdrawal it made psychotic symptoms worse.[1]

Gamfexine
Clinical data
Routes of
administration		Oral
ATC code
  • none
Legal status
Legal status
  • In general: unscheduled
Identifiers
IUPAC name
  • 1-phenyl-1-cyclohexyl-3-dimethylaminopropane
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
Chemical and physical data
FormulaC17H27N
Molar mass245.410 g·mol−1
3D model (JSmol)
SMILES
  • c1ccccc1C(CCN(C)C)C2CCCCC2
InChI
  • InChI=1S/C17H27N/c1-18(2)14-13-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3,5-6,9-10,16-17H,4,7-8,11-14H2,1-2H3 N
  • Key:AJDSHXKJJDQZCJ-UHFFFAOYSA-N N
 NY (what is this?)  (verify)

See also

References
  1. Biel JH (January 1967). "Antidepressants, Stimulants, Hallucinogens". Annual Reports in Medicinal Chemistry. Academic Press. 2: 11–23 (18). doi:10.1016/S0065-7743(08)61499-2.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.